Soluble Neural-Cadherin as a Novel Biomarker for Malignant Bone and Soft Tissue Tumors

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-13-309
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Postoperative Infections in Surgery for Malignant Bone and Soft Tissue Tumors

Orthopedics & Traumatology
2010English

Management of Primary Bone and Soft-Tissue Tumors

Radiology
Nuclear MedicineRadiologyImaging
1976English

Malignant Tumors of Soft Somatic Tissue in Japan

Orthopedics & Traumatology
1977English

Fertility Following Treatment of High-Grade Malignant Bone and Soft Tissue Tumors in Young Adults

Molecular and Clinical Oncology
Cancer ResearchOncology
2014English

Computerized Tomography of Bone and Soft Tissue Tumors

Orthopedics & Traumatology
1978English

N-Cadherin, a Novel Prognostic Biomarker, Drives Malignant Progression of Colorectal Cancer

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2015English

Limb Salvage Procedures for Malignant Soft Tissue Tumors of the Elbow.

Orthopedics & Traumatology
1992English

TNF-α and Tumor Lysate Promote the Maturation of Dendritic Cells for Immunotherapy for Advanced Malignant Bone and Soft Tissue Tumors

PLoS ONE
Multidisciplinary
2012English

The Use of FoxP3 as a Biomarker and Prognostic Factor for Malignant Human Tumors

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy